YOLFTbeta
00

Guiyang Xintian Pharmaceutical Co Ltd

002873 · SHE · Healthcare / Biotechnology

7.53CNY-0.12 (-1.57%)

Price History

Full chart

Market Stats

Previous Close7.65
Open7.65
Day Range7.48 – 7.67
52-Week Range7.04 – 13.05
Volume4.28M
Market Cap2.08B
P/E (TTM)213.50
Forward P/E0.00
EPS0.04
Dividend Yield0.35%
Beta0.01
50-Day Avg8.21
200-Day Avg9.25

About

Guiyang Xintian Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of new traditional Chinese medicines in China. The company offers products in various dosage forms, including hard capsules, oral solutions, granules, gels, tablets, syrups, tinctures, lotions, medicated wines, and elixirs. Its products are used for the treatment of gynecological, urinary tract, breast, thyroid, cardiovascular, anti-tumor, and dental diseases, as well as for oral health; and cold, heat-clearing, and blood-tonifying remedies. The company also engages in research and development; consulting; scientific research; accommodation and catering; technology promotion; pharmaceutical research and development; and health food processing activities. Guiyang Xintian Pharmaceutical Co.,Ltd. was founded in 1995 and is based in Guiyang, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Da Lun Dong
  • Employees1.39K
  • HeadquartersNo. 3 Gaoxin North Road, Guiyang, China, 550000, China
  • Websitehttps://www.gyxtyy.com

Leadership

  • Mr. Da Lun DongGM & Chairman of the Board · b. 1964
  • Mr. Jin Hua WangVice Chairman & Deputy GM · b. 1967
  • Ms. Zhihui ZengCFO & Accounting Supervisor · b. 1973
  • Mr. Guangping WangDeputy GM, Director & Board Secretary · b. 1970
  • Mr. Mao Chen WeiDeputy General Manager · b. 1983

Financials

Income Statement

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue330.09M406.13M454.13M521.91M633.19M681.71M694.26M773.34M750.95M969.84M1.09B953.98M857.55M749.72M
Growth (%)-+23.04%+11.82%+14.93%+21.32%+7.66%+1.84%+11.39%-2.90%+29.15%+12.15%-12.29%-10.11%-12.57%
Cost of Revenue78.98M85.70M81.85M85.87M115.44M132.73M146.03M163.02M165.86M201.16M247.65M219.39M230.72M213.07M
Gross Profit251.11M320.43M372.28M436.04M517.74M548.99M548.23M610.32M585.09M768.69M840.02M734.59M626.83M536.65M
Gross Margin76.07%78.90%81.98%83.55%81.77%80.53%78.97%78.92%77.91%79.26%77.23%77.00%73.10%71.58%
Operating Expense215.56M306.88M337.87M392.96M456.13M474.27M473.64M526.88M498.73M651.57M718.10M640.85M563.63M506.53M
Operating Income35.55M13.55M34.41M43.08M61.62M74.71M74.59M83.43M86.36M117.11M121.92M93.74M63.20M30.12M
Operating Margin10.77%3.34%7.58%8.25%9.73%10.96%10.74%10.79%11.50%12.08%11.21%9.83%7.37%4.02%
EBITDA41.67M29.63M54.97M67.25M88.32M88.92M97.93M105.99M110.09M156.66M157.88M125.68M110.65M66.96M
EBITDA Margin12.62%7.30%12.11%12.89%13.95%13.04%14.11%13.71%14.66%16.15%14.52%13.17%12.90%8.93%
Net Income26.39M15.09M33.12M42.01M57.07M66.12M70.98M71.42M74.10M100.61M111.52M80.87M52.32M9.11M
Net Income Margin8.00%3.72%7.29%8.05%9.01%9.70%10.22%9.24%9.87%10.37%10.25%8.48%6.10%1.22%
R&D11.29M12.37M11.24M13.08M13.92M23.08M31.83M21.10M13.30M20.38M21.58M38.13M40.47M42.55M
R&D as % of Total Revenue3.42%3.04%2.47%2.51%2.20%3.39%4.59%2.73%1.77%2.10%1.98%4.00%4.72%5.68%
Interest Expense8.58M9.75M11.53M11.74M11.81M2.38M3.00M6.94M7.06M18.27M11.90M12.93M18.86M17.76M
Interest Expense % of Total Revenue2.60%2.40%2.54%2.25%1.86%0.35%0.43%0.90%0.94%1.88%1.09%1.36%2.20%2.37%

Balance Sheet

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets336.84M379.74M467.76M499.36M549.54M856.40M984.31M1.08B1.54B1.52B1.84B1.91B1.95B2.12B
Total Liabilities158.40M222.36M277.26M273.05M270.33M234.30M323.72M374.89M707.64M633.98M714.65M798.47M755.79M864.83M
Total Equity178.44M157.38M190.50M226.31M279.21M622.11M658.72M707.44M828.30M890.44M1.13B1.11B1.19B1.26B
Cash43.18M22.79M71.14M42.90M62.50M86.50M139.25M181.66M330.09M72.48M100.67M138.24M118.16M173.72M
Total Debt108.00M148.60M216.40M199.60M192.22M140.51M212.77M254.47M564.43M429.79M486.17M571.83M534.41M-
Net Debt64.82M125.81M145.26M156.71M129.71M54.00M73.52M72.81M234.35M357.31M385.51M433.59M416.25M342.93M

Cash Flow

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow21.41M13.88M37.30M40.73M61.34M62.06M47.59M33.73M175.77M124.30M75.82M77.78M88.13M83.73M
Investing Cash Flow-39.43M-34.91M-38.21M-30.67M-13.77M-248.27M-26.79M-3.34M-326.67M-217.61M-79.17M-96.70M-46.37M-
Financing Cash Flow1.78M-3.41M49.26M-38.30M-27.97M210.21M31.95M12.02M299.33M-164.30M31.54M56.48M-61.83M-
Capital Expenditure54.47M35.85M39.38M33.66M13.77M105.21M40.54M156.07M68.15M105.69M129.20M101.70M61.45M51.59M
Free Cash Flow-33.06M-21.97M-2.08M7.08M47.57M-43.15M7.05M-122.35M107.62M18.61M-53.38M-23.92M26.68M32.14M
Dividends Paid7.56M40.22M15.31M18.89M19.15M19.73M21.87M5.78M11.49M14.01M19.89M42.53M35.06M41.42M
FCF to OCF-154.45%-158.31%-5.56%17.37%77.55%-69.53%14.82%-362.74%61.23%14.97%-70.41%-30.75%30.27%38.38%
Dividend Paid to FCF-22.85%-183.04%-737.86%266.96%40.26%-45.72%310.17%-4.72%10.68%75.31%-37.25%-177.79%131.43%128.88%

Earnings

Report DateJun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 28, 2020Aug 28, 2020Oct 29, 2020Dec 31, 2020Apr 30, 2021Jun 30, 2021Sep 30, 2021Mar 25, 2022Apr 28, 2022Aug 29, 2022Oct 30, 2022Mar 27, 2023Apr 27, 2023Aug 28, 2023Oct 29, 2023Mar 28, 2024Apr 26, 2024Aug 28, 2024Oct 28, 2024Dec 31, 2024Apr 25, 2025Jun 30, 2025Oct 27, 2025Dec 31, 2025Apr 23, 2026Jun 30, 2026
EPS Estimate-------------------------------------
EPS Actual0.060.140.020.070.070.140.030.080.080.150.010.030.180.290.060.210.090.170.050.130.110.190.050.100.090.17-0.030.060.060.14-0.040.020.010.04-0.030.010.01
Surprise-------------------------------------
Timing------------------After-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hours-Pre-market-Pre-market-Pre-market-

Key Statistics & Ratios

Market Cap2.08B
Enterprise Value2.47B
Trailing P/E213.50
Forward P/E0.00
Price / Sales2.88
Price / Book1.61
EPS0.04
Book Value5.38
Revenue (TTM)723.26M
Gross Profit (TTM)518.52M
EBITDA59.43M
Profit Margin1.14%
Operating Margin3.77%
Return on Equity0.67%
Return on Assets0.86%
Shares Outstanding244.10M
Shares Float160.78M
Beta0.01
Dividend Yield0.35%
Dividend Rate0.03
Payout Ratio85.96%

Dividends

20261×
0.03May 27, 2026
20252×
0.06Jun 3, 20250.04Jan 20, 2025
20241×
0.07Jun 25, 2024
20231×
0.10Jun 1, 2023
20221×
0.09Jul 7, 2022
20211×
0.06Jul 14, 2021
20201×
0.05Aug 13, 2020
20191×
0.03Jun 13, 2019
20181×
0.06Jul 4, 2018

Stock Splits

  • Oct 28, 20221.4:1
  • Nov 10, 20211.4:1
  • Jul 4, 20181.7:1